Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine-Reference-Cited by-同舟云学术

Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine

Published:2007-03-30 Issue:6 Volume:21 Page:768-771
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Laurent Christian,Kouanfack Charles,Koulla-Shiro Sinata,Njoume Maguy,Nkene Yvette Mawamba,Ciaffi Laura,Brulet Charlotte,Peytavin Gilles,Vergne Laurence,Calmy Alexandra,Mpoudi-Ngolé Eitel,Delaporte Eric

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference19 articles.

1. Ensuring the safety of HIV/AIDS generics;Adelman;Lancet,2005

2. A combined-formulation tablet of lamivudine/nevirapine/stavudine: bioequivalence compared with concurrent administration of lamivudine, nevirapine, and stavudine in healthy Indian subjects;Narang;J Clin Pharmacol,2005

3. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial;Laurent;Lancet,2004

4. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults;Laurent;J Acquir Immune Defic Syndr,2005

5. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa;Coetzee;AIDS,2004

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults;International Journal of Infectious Diseases;2017-08

2. Generic antiretrovirals for the treatment of HIV: a novel challenge for Western countries?;Int. Journal of Clinical Pharmacology and Therapeutics;2017-05-01

3. Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011–2012;BMC Infectious Diseases;2016-10-03

4. Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study;PLOS ONE;2016-06-20

5. Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and Internet pharmacies;Journal of Clinical Pharmacy and Therapeutics;2014-11-10